Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1801 to 1825 of about 5901

Previous 25

Website Changes

10/05/2015

Novocure Announces CE Mark and First Patient Use of Second Generation Optune System

10/05/2015

Musella Foundation Copayment Assistance program has reopened!

10/05/2015

FDA Expands Optune`s Glioblastoma Multiforme Indication

10/05/2015

Musella Foundation Drug Discount Card Update

10/04/2015

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration in Patients with Aggressive Form of Brain Cancer

10/01/2015

With $55M, Neon Wants To Make the Cancer Vaccine “Problem” Personal

10/01/2015

Multicenter study shows Monteris’ NeuroBlate System improves outcome in brain tumor patients

09/30/2015

IBTA Newsletter

09/28/2015

International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme.

09/28/2015

5th Annual Chili Cook Off October 3, 2015 Saturday 11 am – 5 pm NJ

09/20/2015

EnGeneIC Ltd. to Initiate U.S. Phase 1 Clinical Study Using Targeted EDV™ Nanocells to Treat Advanced Glioma Patients

09/20/2015

Brain cancer drug approved for NZ

09/20/2015

Caffeine inhibits the growth of glioblastomas through activating the caspase-3 signaling pathway in vitro.

09/12/2015

Novocure to Present the Latest Data from the EF-14 Clinical Trial in Newly Diagnosed GBM at the 15th Interim Meeting of the World Federation of Neurosurgical Societies

09/12/2015

Life After Brain Cancer Diagnosis: Max`s Story

09/08/2015

Novocure Announces Optune® Now Available at more than 200 Leading Cancer Centers across the United States

09/04/2015

Voices Against Brain Cancer is now accepting Brain Tumor Research Grant Requests

09/01/2015

UCLA Researchers Develop a Likely New Combo Treatment for the Deadliest Form of Brain Cancer

09/01/2015

Oncoceutics Awarded Grant for Phase II Brain Cancer Trial

08/31/2015

IBTA Newsletter

08/29/2015

Computed modeling of alternating electric fields therapy for recurrent glioblastoma.

08/26/2015

WEBINAR ALERT: Consensus Recommendations for a Standardized Brain Tumor Imaging Protocol (BTIP) in Clinical Trials

08/26/2015

Enrollment Begins In Expansion Phase of ONC201 Clinical Trial

08/26/2015

Treating Brain Tumor with Microbeam Radiation Generated by a Compact Carbon-Nanotube-Based Irradiator: Initial Radiation Efficacy Study.

08/25/2015

FDA Grants Orphan Drug Designation for Tocagen`s Toca 511 & Toca FC, an Investigational Immuno-Oncology Treatment for Glioblastoma

Our privacy / cookie policy has changed.
Click HERE to read it!